Crinetics Pharmaceuticals, Inc. (CRNX)
NASDAQ·Healthcare·Biotechnology
$37.99
-1.63%
Mkt Cap $4.01B
EPS — Estimate vs Actual
Revenue — Estimate vs Actual
Quarterly History
| Q1 2026 Feb 26, 2026 | $4.49M | $6.16M | +37.22% | -$1.37 | -$1.29 | +5.84% | — | — |
| Q4 2025 Nov 6, 2025 | $4.32M | $143.00K | -96.69% | -$1.27 | -$1.38 | -8.66% | — | — |
| Q3 2025 Aug 7, 2025 | $394.00K | $1.03M | +161.68% | -$1.13 | -$1.23 | -8.85% | — | — |
| Q2 2025 May 8, 2025 | $347.91K | $361.00K | +3.76% | -$0.99 | -$1.04 | -5.05% | — | — |
| Q1 2025 Feb 27, 2025 | $727.27K | — | — | -$0.92 | -$0.88 | +4.35% | — | — |
| Q4 2024 Nov 12, 2024 | $218.09K | — | — | -$0.91 | -$0.96 | -5.42% | — | — |
| Q3 2024 Aug 8, 2024 | $510.00K | $399.00K | -21.76% | -$0.86 | -$0.94 | -9.30% | — | — |
| Q2 2024 May 9, 2024 | $260.00K | $640.00K | +146.15% | -$0.84 | -$0.93 | -10.71% | — | — |
| Q1 2024 Feb 28, 2024 | $260.00K | — | — | -$0.89 | -$0.90 | -1.12% | — | — |
| Q4 2023 Nov 7, 2023 | $190.00K | $346.00K | +82.11% | -$0.89 | -$1.01 | -13.48% | — | — |
| Q3 2023 Aug 8, 2023 | $140.00K | $988.00K | +605.71% | -$0.85 | -$0.94 | -10.59% | — | — |
| Q2 2023 May 4, 2023 | $630.00K | $2.68M | +325.24% | -$0.82 | -$0.85 | -3.66% | — | — |
| Q1 2023 Feb 28, 2023 | $250.00K | $709.00K | +183.60% | -$0.82 | -$0.84 | -2.44% | — | — |
| Q4 2022 Nov 14, 2022 | $250.00K | $458.00K | +83.20% | -$0.78 | -$0.78 | +0.00% | — | — |
| Q3 2022 Aug 12, 2022 | $600.00K | $439.00K | -26.83% | -$0.62 | -$0.81 | -30.65% | — | — |
| Q2 2022 May 12, 2022 | $5.20M | $3.13M | -39.79% | -$0.56 | -$0.73 | -30.36% | — | — |
| Q1 2022 Mar 30, 2022 | — | $1.08M | — | -$0.57 | -$0.68 | -19.30% | — | — |
| Q4 2021 Nov 5, 2021 | — | — | — | -$0.70 | -$0.73 | -4.29% | — | — |
| Q3 2021 Aug 10, 2021 | — | — | — | -$0.60 | -$0.70 | -16.67% | — | — |
| Q2 2021 May 6, 2021 | — | — | — | -$0.65 | -$0.69 | -6.15% | — | — |